Polycystins and cellular Ca2+ signaling
- 1.7k Downloads
The cystic phenotype in autosomal dominant polycystic kidney disease is characterized by a profound dysfunction of many cellular signaling patterns, ultimately leading to an increase in both cell proliferation and apoptotic cell death. Disturbance of normal cellular Ca2+ signaling seems to be a primary event and is clearly involved in many pathways that may lead to both types of cellular responses. In this review, we summarize the current knowledge about the molecular and functional interactions between polycystins and multiple components of the cellular Ca2+-signaling machinery. In addition, we discuss the relevant downstream responses of the changed Ca2+ signaling that ultimately lead to increased proliferation and increased apoptosis as observed in many cystic cell types.
KeywordsCalcium signaling Polycystin ADPKD Renal pathology
Autosomal dominant polycystic kidney disease (ADPKD) affects more than 1 in 1,000 live births and is the most common monogenic cause of kidney failure in humans [1, 2, 3, 4]. ADPKD is characterized by the progressive formation and enlargement of renal cysts, typically leading to chronic renal failure by late middle age. In most cases, the disease arises as a consequence of mutations in the PKD1 or PKD2 genes, which encode the proteins polycystin-1 and -2, respectively. Mutations in the PKD1 gene account for approximately 85 % (ADPKD type 1), and mutations in the PKD2 gene account for approximately 15 % (ADPKD type 2) of the affected individuals . Disease progression is typically more rapid in ADPKD type 1, with a mean age of end-stage renal disease approximately 20 years earlier than in type 2, but in all other respects ADPKD types 1 and 2 share almost identical disease phenotypes. This suggests that polycystin-1 and -2 function in common pathways, implying that loss of activity of either protein results in a very similar disease manifestation . The biological role of the polycystin proteins and the molecular basis by which mutational malfunction of either of them leads to cystogenesis, have proven to be very complex, and have been discussed in several recent reviews [1, 2, 6, 7, 8, 9, 10, 11, 12, 13]. A widely accepted view is that polycystin-1 and -2 are functionally associated in a receptor-ion channel complex, in which polycystin-1 acts as a receptor that gates the Ca2+-permeable polycystin-2 channel [14, 15]. Polycystin-1 (4,302 amino acids) contains a large extracellular N-terminal domain, 11 predicted transmembrane spanning segments, and an intracellular C-terminus . The extracellular region of polycystin-1 contains >3,000 amino acids and is implicated in cell–cell and cell–matrix interactions. Polycystin-1 is cleaved at its predicted G-protein-coupled receptor proteolytic site, a feature that could be essential for its biological activity . The intracellular C-terminus of polycystin-1 contains a coiled-coil domain that is involved in the physical interaction with other proteins, and in particular with polycystin-2 [18, 19]. Polycystin-2 is a smaller transmembrane protein (968 amino acids) predicted to have six transmembrane regions and sharing significant homology with transient receptor potential (TRP) channels [9, 12, 13, 20]. Better understanding of the role of the polycystin-1/polycystin-2 complex came from the observation that this co-assembly produced cation-permeable currents at the plasma membrane , and participated in mechano-sensation and flow-dependent Ca2+ signaling in the primary cilium . As reviewed recently, there is a clear connection between polycystic kidney disease and dysfunction of ciliary proteins . The precise cellular function of the polycystin proteins is, however, still not completely understood, particularly as both polycystins have been found in cellular locations other than the cilium . Polycystin-1 has been localized to cell–cell junctions and both apical and basolateral membranes [23, 24]. Polycystin-2 is a resident endoplasmic-reticulum (ER) protein  and its trafficking is highly regulated [26, 27, 28, 29]. The differential localization of both polycystins also suggests that these proteins may display different cellular functions either alone or as a protein complex [29, 30]. Several cellular mechanisms have been proposed to explain cyst formation and cyst growth including a change in cell polarity , an altered matrix composition , and remarkably, a disturbed balance between cell proliferation and apoptosis . The view that polycystin-2 is a potential Ca2+ channel and polycystin-1 is a receptor regulating its activity, suggests that intracellular Ca2+ signaling could be one of the most proximal events in many cellular functions of the polycystins and consequently in the dysfunctional mechanisms that may lead to cyst formation. Clearly, the Ca2+ effects are not limited to the restricted compartment of the cilium but will also involve Ca2+ influx from other parts of the plasma membrane as well as Ca2+ release from the ER. The situation becomes even more complex as polycystin-2 was found to associate with other Ca2+ channels in the plasma membrane (TRPC1 [34, 35] and TRPV4 ), and in intracellular membranes (inositol 1,4,5-trisphosphate receptor (IP3R) [37, 38] and ryanodine receptor (RyR) ). Moreover, polycystin-1 has been found to interact with basic components of the Ca2+ toolkit such as the IP3R  and the stromal interaction molecule-1 (STIM1) . Hence, polycystins may affect Ca2+ signaling in many different ways, including effects on cytosolic or ER Ca2+ concentration, global or local Ca2+ changes, Ca2+ oscillations, intracellular Ca2+-leak pathways or plasma-membrane Ca2+ influx or a combination of these effects. However, the cellular role of polycystins in Ca2+ signaling, and the downstream parameters that may link the disturbed Ca2+ signaling in ADPKD to cyst formation, are not yet understood . In this review, we provide an update of the different effects of polycystins on cellular Ca2+ signaling. We also discuss the current view on the downstream signaling pathways that could be affected by the dysfunctional Ca2+ signals in ADPKD, ultimately leading to a cystic phenotype with increased proliferation and increased apoptosis.
Disturbed cellular Ca2+ fluxes in ADPKD
Cilium and plasma membrane
There has been some confusion regarding the structural model for the polycystin-1/-2 complex. A newly identified coiled-coil domain in the C-terminus of polycystin-2 (a.a. 839–873), different from a more upstream coiled-coil domain (a.a. 772–796) , has been proposed to mediate assembly into a homotrimer to which a single coiled-coil domain in the C-terminus of polycystin-1 (a.a. 4214–4248) can bind [48, 49]. Other evidence, obtained by atomic force microscopy, however, showed that the polycystin-1/-2 complex assembles as a tetramer with a 2:2 stoichiometry . The latter is more in line with recently described homo- and heteromeric polycystin-2 channel properties suggesting fourfold symmetry [35, 36, 51]. Differences between both models may be due to different structural properties of the helix containing a coiled-coil-domain motif, which may oligomerize differently as an isolated peptide than when embedded in the folded protein . Deletion of this polycystin-2 coiled-coil domain (referred to as CC2 domain) indicated that although this domain is required for heterotypic interaction with polycystin-1, it does not represent the binding site itself . In agreement with earlier studies [19, 48], the domain responsible for binding was found distal from CC2 (a.a. 872–895). Furthermore, there is evidence for a dimerization site in polycystin-2, N-terminally located of the first transmembrane domain, which regulates channel tetramerization . Although CC2 is considered an assembly domain, it does not seem to have a prominent role in the self-association of polycystin-2 . Polycystin-2 channels with CC2 deletions still tetramerize , and C-terminal mutants can co-immunoprecipitate full-length polycystin-2 . The role of the C-terminus of polycystin-2 may therefore be to provide an essential scaffolding platform for heteromeric assembly with other channel proteins, including polycystin-1 , TRPC1 , TRPV4 , and the IP3R .
The polycystin-2 C-terminus is important for the regulation of the Ca2+-channel activity [54, 55, 56]. An EF-hand motif was identified connected by a linker to a coiled-coil domain overlapping with CC2 . An affinity for Ca2+ in the micromolar range was found for the EF-hand domain by isothermal titration calorimetry. This region may therefore sense local Ca2+ concentration changes and operate as a Ca2+-sensitive switch with a role in proper folding and oligomerization of polycystin-2  and subsequent channel gating .
Polycystin-2 can form spontaneously active nonselective cation channels in lipid bilayers [35, 57, 58]. Analysis of the channel properties revealed a high-conductance, nonselective, voltage-dependent cation channel . Using various organic cations of different size, the pore diameter was estimated to be at least 1.1 nm . Heterologous expression in Xenopus oocytes revealed a channel that is sensitive to changes of the cytosolic Ca2+ concentration . Spontaneous activity of polycystin-2 was, however, not always obtained upon heterologous expression of polycystin-2 and polycystin-1 , which clearly illustrates the difficulty in identifying the physiological activation mechanisms of polycystin-2 or of the polycystin-1/-2 complex. An even larger complexity is suggested from the observations that polycystin-2 may associate and perhaps form heteromeric channels with other TRP-family members such as TRPC1 [34, 35, 51], TRPC4 , and TRPV4  (Fig. 1). The function and regulation of polycystin-2 at the plasma membrane downstream of mechanical stimulation, cell-surface receptors, and cell adhesion, were recently discussed in an excellent review . A role for polycystin-2 as a mechanosensitive channel has been suggested from measurements of changes in the cytosolic Ca2+ concentration in response to fluid flow [22, 62, 63, 64]. Also, regulation of polycystin-2-channel activity by environmental signals such as hydrostatic and osmotic pressure  and by cytoskeletal  and microtubular  elements in the human syncytiotrophoblast supports such a role. Mechanosensitivity of polycystin-2 may result from its interaction with TRPV4, which was required for fluid flow-induced Ca2+ entry in Madin–Darby canine kidney (MDCK) cells . Loss of TRPV4, however, did not result in cyst formation, which suggests that mechanosensitive activation of this channel complex alone is not sufficient for cyst formation . Polycystin-2 can also function as a bona fide receptor-operated channel downstream of epidermal growth factor (EGF) receptor activation . EGF-induced activation of polycystin-2 required the activation of phospholipase C (PLC). Polycystin-2 interacted with PLC-γ2 and colocalized in the primary cilium with the EGF receptor and phosphatidyl inositol 4,5-bisphosphate (PIP2) . EGF-induced activation of PIP2 breakdown resulted in the relieve of PIP2-mediated inhibition of polycystin-2 . The localization of the EGF receptor in the primary cilium could represent a sensitization of the polycystin-2-channel activity with implications for cilium-based mechano-transduction, as it may reduce its threshold for activation by mechanical stimulation . Channel activity of polycystin-2 complexed with TRPC1 but not with polycystin-1 could also be activated in response to PLC-coupled bradykinin-receptor stimulation . This polycystin-2/TRPC1 channel with distinct properties from the polycystin-1/-2 complex has implications in mechano-sensation and cilium-based Ca2+ signaling . Homologs of polycystin-1 and -2 have been shown to form receptor channel complexes acting as sour-taste receptors . As there is increasing evidence from several gene-inactivation studies indicating that cilium-mediated mechano-transduction is not alone responsible for cyst formation, receptor-operated activation may play an important role [36, 51, 70, 71, 72]. A combined mechanism of flow-dependent delivery of a ligand would thereby become an intriguing possibility .
The intracellular distribution of polycystin-2 is very complex, with the largest pool in the ER in addition to its localization at the plasma membrane and in more restricted domains such as the primary cilium and mitotic spindles as discussed in several reviews [3, 27, 73]. Next to its role as a plasma-membrane Ca2+ channel and its ciliary function in complex with polycystin-1, polycystin-2 was proposed to have a function in intracellular Ca2+ release [25, 58]. Other findings, however, suggested that whereas heterologous expression of polycystin-2 showed a predominant ER localization, endogenous polycystin-2 was found primarily in the cilium and plasma membrane of mouse inner medullary collecting duct (IMCD) cells and in MDCK cells . The long-standing controversy about this differential distribution has been clarified to some extent by the identification of specific signal sequences and trafficking proteins [3, 30, 60, 75]. A stretch of acidic amino acids in the C-terminus of polycystin-2 functions as an ER-retention signal by binding phosphofurin acidic cluster-sorting proteins (PACS-1 and -2) [25, 28]. Binding of PACS-1 and PACS-2 requires polycystin-2 phosphorylation by casein kinase II (CK-II) at Ser 812, and mediates retrieval back to the trans-Golgi network (PACS-1) and the ER (PACS-2), respectively . Prevention of this phosphorylation in the Caenorhabditis elegans polycystin-2 homologue promoted its translocation to the cilium . Polycystin-2 interactor Golgi- and ER-associated protein (PIGEA-14) is another regulator of polycystin-2 trafficking, causing its movement to a putative trans-Golgi compartment . Plasma-membrane, but not cilia, localization of polycystin-2 is regulated by glycogen synthase kinase 3 (GSK3) phosphorylation of Ser 76 in the N-terminus . In the presence of specific GSK3 inhibitors, the lateral plasma-membrane pool of endogenous polycystin-2 redistributes into an intracellular compartment in MDCK cells without any change in primary-cilia localization . Furthermore, the N-terminus of polycystin-2 contains a motif (R6V7xP8), which is required for localization in the cilia . Cyst cells expressing an ADPKD-associated polycystin-1 mutant had decreased amounts of both polycystin-1 and -2 in the primary cilium, indicating that impairing the function of one protein negatively affects the localization of the other .
An interaction between the C-termini of polycystin-1 and polycystin-2 is considered to be important for activation of the Ca2+-channel activity [14, 21]. This does not necessary require a co-localization in the same membrane, and a model for interaction with polycystin-2 either localized in the plasma membrane or in the ER has been proposed [47, 81]. The concept that polycystin-2 may be a novel type of intracellular Ca2+-release channel was based on the observation that polycystin-2 exogenously expressed in LLC-PK1 epithelial cells caused a marked augmentation of intracellular Ca2+ release upon vasopressin stimulation . A similar role as an intracellular Ca2+-release channel was also found for the endogenous homologue of polycystin-2 in Caenorhabditis elegans . The open probability of the channel was increased by Ca2+ in the physiological range (0.1–10 μM), whereas higher cytosolic [Ca2+] lowered the open probability . The observation that polycystin-2 may function as a CICR channel was further strengthened by the sensitization towards Ca2+ upon CK-II phosphorylation at the C-terminal S812 site . Polycystin-2-mediated Ca2+ release from the ER required activation of the IP3R [37, 58]. Moreover, it was demonstrated that polycystin-2 and the IP3R physically interact and the C-terminus of polycystin-2 is required for this interaction  (Fig. 1). The binding site was further identified as the acidic cluster in the C-terminus of polycystin-2, which interacts with a cluster of basic residues in the N-terminal suppressor domain of the IP3R . Disruption of this molecular interaction by using competitive peptides eliminated the stimulation of IP3-induced Ca2+ release (IICR) by polycystin-2. In both studies, the channel death mutant (D511 V) did not provoke stimulation of IICR, which is a strong indication that polycystin-2 operates as a CICR channel that becomes activated by IICR in the immediate proximity of the IP3R-channel pore. Activation appears to be restricted to a microdomain of IICR as reduction of this microdomain by the fast Ca2+ buffer BAPTA eliminated activation of the CICR via polycystin-2, whereas the slower Ca2+ buffer EGTA did not have such effect . It is conceivable that ER-localized polycystin-2 is silent in resting conditions as inappropriate opening of this channel would represent a Ca2+ leak from the ER eventually resulting in ER depletion and an ER-stress response . At variance with these data, it was observed that exogenous expression of polycystin-2 in HeLa cells increased the ER Ca2+ permeability, which resulted in lowering of the ER Ca2+ content and a decrease in the histamine-evoked Ca2+ response . The IP3R was not required for the polycystin-2-mediated reduction of the ER Ca2+ load, which suggested that polycystin-2 forms an independent ER Ca2+-leak channel . The apparently contradictory results regarding amplification of IICR as a result of CICR via polycystin-2 [37, 38, 58], versus a diminished IICR due to ER Ca2+-store depletion , can possibly be reconciled by the cell- and condition-specific factors that regulate activation of polycystin-2 in the ER. Syntaxin-5, an ER- and Golgi-associated t-SNARE that functions in vesicle targeting and fusion, was found to directly interact with polycystin-2 and to inactivate its channel activity . Syntaxin-5 was proposed to have a function in preventing the Ca2+ leak from the ER via polycystin-2. LLC-PK1 cells expressing Δ(5–72) polycystin-2 that lacks the syntaxin-5-binding site had a reduced ER Ca2+ content and a concomitant lower increase in cytosolic [Ca2+] upon agonist stimulation . Polycystin-2 in the ER may therefore play an important role for controlling ER Ca2+ levels and its activity may be tightly controlled. Among the other polycystin-2-interacting proteins, polycystin-1 , α-actinin , mammalian diaphanous-related forming 1 (mDIA-1) , and fibrocystin  have been found to modulate polycystin-2′s activity.
Polycystin-2 was also found to bind and regulate the RyR2 in the sarcoplasmic reticulum (SR) of cardiac myocytes . The C-terminus of polycystin-2 functionally inhibited the RyR2 channel and polycystin-2-deficient cardiomyocytes showed changes in store content and Ca2+-release properties. This altered RyR2 function could play a role in the development of cardiovascular abnormalities in ADPKD patients .
On the one hand, polycystin-2 can act as a regulator of other ER/SR channels, but on the other hand, it has its own channel properties that may be controlled by different cellular parameters. An obvious candidate for the regulation of polycystin-2′s channel properties in the ER is polycystin-1. As stated above, models were proposed for interaction of polycystin-1 in the plasma membrane with polycystin-2 in the ER [47, 81]. Although it is still unclear what the function could be of polycystin-1 at the level of the ER, there is compelling evidence that a significant amount of polycystin-1 is also localized there [43, 91]. This is particularly the case for shorter C-terminal cleavage forms, which were shown to functionally interact with the IP3R thereby inhibiting IICR . The interaction site was found to be the IP3R ligand-binding domain similarly to the binding site for polycystin-2 but with an opposite effect. It was therefore proposed that polycystin-1 and polycystin-2 both interact with the IP3R in a complementary way to maintain a balance of proper ER-mediated Ca2+ signaling . A different result was obtained by other authors , showing that exogenous expression of polycystin-1 in MDCK cells accelerated the decay of ligand-activated cytoplasmic Ca2+ transients. These data were interpreted as due to an inhibition of the Ca2+ leak across the ER membrane. These studies clearly illustrate the importance of polycystins in maintaining proper ER Ca2+ homeostasis . Another unexpected finding, consistent with the reduction of the intracellular Ca2+ responses, was the identification of a P100 C-terminal fragment of polycystin-1 that is localized in the ER and interacts with STIM1 . P100 probably contains the six C-terminal transmembrane domains and the C-terminal tail. It would interact with STIM1 via its coiled-coil domain and thereby interfere with the translocation of STIM1 to the plasma membrane, inhibiting the activation of store-operated Ca2+ currents. This would then lead to decreased store filling and subsequently to diminished agonist-induced Ca2+ transients . It should be noted, however, that the expression of the C-terminal tail of polycystin-1 as a fusion protein yielded an opposite result and led to an increase in the cytosolic Ca2+ concentration and store-operated Ca2+ entry (SOCE) [94, 95]. This discrepancy may be due to a dominant negative effect of the polycystin-1 C-terminus, given the observation that the formation of P100 actually requires the presence of full-size polycystin-1 . The nature of the polycystin-1 cleavage responsible for P100 generation and the significance of this mechanism are as yet unknown, but these findings clearly illustrate the importance of polycystin-1 as well as polycystin-2 for ER Ca2+ signaling. Mechanistically, polycystin-1 was proposed to increase the interaction between the IP3R and STIM1, which thereby inhibited Ca2+ release and SOCE  (Fig. 1). This regulation implicated the activation of the phosphatidylinositol 3-kinase (PI3-K)/protein kinase B (AKT) signaling pathway and would act upon a protein complex involving polycystin-2/IP3R/STIM1. It should be pointed out, however, that in a study comparing STIM1−/− and wild-type MEF cells, no evidence was found for a direct interaction between STIM1 and the IP3R, but the effects on IICR were attributed to changes in the connections between the ER and plasma membrane .
The effects of polycystin-1 on ER Ca2+ release were mostly obtained by exogenous expression of polycystin-1 or its C-terminal fragments. The properties of endogenous polycystin-1 as obtained from knock-down experiments are much less documented. In studies of polycystin-1 haploinsufficiency in renal cells  or in vascular cells , the results pointed to a decreased resting cytosolic Ca2+ concentration in the polycystin-1+/− as compared to the wild-type cells. Moreover, vascular smooth-muscle cells from polycystin-1+/− mice exhibited a decreased agonist-induced Ca2+ release as compared to the wild type . This result is in contrast to the data obtained with exogenous polycystin-1 expression, but it is more in line with the general concept that polycystin-1 and polycystin-2 form a functional complex with Ca2+-channel properties. Disturbance of this complex by either polycystin-2 or polycystin-1 knock-out is then expected to result in a decreased Ca2+-release activity. This is exactly what was recently found for the effect on IICR in a model system of plasma membrane-permeabilized cells upon lentiviral knock-down of either or both polycystins . The presence of both polycystins seemed to be required for stimulation of Ca2+ release from the ER and knock-down of either polycystin decreased the apparent sensitivity of IICR . The conflicting results from different groups may be caused by the fact that on the one hand exogenous expression may result in abnormal processing, trafficking and localization, and on the other hand knock-out or knock-down of endogenous genes may result in adaptive responses. For both approaches, the unraveling of the detailed mechanism is presently not at hand, but it becomes increasingly clear that both polycystins are implicated in ER-related Ca2+ fluxes. An interesting view that was presented in a model by the Guggino group , proposed a role for polycystin-1 in preventing a phenotype with more IICR and SOCE-mediated Ca2+ fluxes and promoting a situation with more filled stores and inactivated SOCE with Ca2+ influx via plasma membrane (or cilia)-localized polycystin-2 (Fig. 1). While not all data are easily reconciled with this model, it presents the very appealing idea that defective polycystins in ADPKD provoke a shift in the spatial properties of intracellular Ca2+ signals with the appearance of different microdomains with altered cytosolic Ca2+ concentrations, which can then elicit different downstream effects.
Downstream effects of Ca2+ signaling in ADPKD
Effects on cAMP signaling
Disturbed Ca2+ signaling is a proximal event in ADPKD and it directly or indirectly affects several other very important signaling pathways . Among these, an increased cAMP concentration is a common finding in different models of ADPKD and cAMP stimulates cyst fluid and electrolyte secretion , possibly involving the stimulation of the cystic fibrosis transmembrane conductance regulator (CFTR) . The reasons for the high cytosolic cAMP concentration in cyst cells are not very well understood. The polycystin proteins may alter the activity of G-protein-coupled receptors, like the V2 vasopressin receptor, that signal via cAMP [102, 104]. A link with cellular Ca2+ homeostasis was proposed via the activity of Ca2+-inhibitable adenylyl cyclase (AC) and/or Ca2+-dependent phosphodiesterase (PDE) . The interaction between cytosolic Ca2+ and cAMP is, however, very complex, as there are nine different genes encoding transmembrane-domain ACs (AC1–9) along with numerous splice variants of the gene encoding soluble ACs, while also the cyclic nucleotide-PDE superfamily consists of over 30 genes . Moreover, different members of these families are sensitive to Ca2+, either directly or via calmodulin. A common theme in the regulation of cAMP production is the pronounced intracellular compartmentalization. Three modes of cAMP microdomain/compartment formation are found: via (a) lipid rafts, (b) A-kinase anchor proteins (AKAPs), and (c) targeting of soluble AC to cellular organelles . It can therefore be anticipated that a relation between polycystin dysfunction and the cAMP levels in ADPKD may be very much linked to specific microdomains either at the plasma membrane or at intracellular membranes and may involve particular AC or PDE isoforms. In this respect, it was recently demonstrated that the primary cilium plays an important role as a subcellular cAMP-signaling compartment . A protein complex comprising AKAP150, AC5/6, and protein kinase A (PKA) was found in primary cilia of renal epithelial cells. Polycystin-2 and PDE4C were further identified as components of this ciliary AKAP complex. Under normal conditions PDE4C would promote the hydrolysis of cAMP and polycystin-2 could provide local accumulation of Ca2+ that inhibits the Ca2+-sensitive AC5 and AC6. Malfunction of polycystin-2 as a Ca2+ channel may reduce the local Ca2+ concentration in the cilium and thereby activate AC5/6. Other mechanisms like mutations of the transcription factor hepatocyte nuclear factor-1ß (HNF-1ß) were found to inhibit the expression of PDE4C and thereby increase cAMP levels . As HNF-1ß also regulates the expression of Pkd2 itself , downregulation of polycystin-2 and subsequent impaired ciliary trafficking of the AKAP complex may also contribute to the elevation of cAMP levels . PDE1 isoforms (PDE1a, PDE1b, and PDE1c) are expressed to high levels in the kidney cells . Importantly, these PDE isoforms are also regulated by cytosolic Ca2+, which in ADPKD would result in decreased PDE activity and a higher cAMP concentration . An additional mechanism that could be important in ADPKD is cAMP production related to Ca2+-store depletion and STIM1 translocation . These data are indicative of a mechanism of store-operated cAMP signaling, in which lowering of the Ca2+ concentration in the ER led to recruitment of ACs through a process involving STIM1 . This mechanism was also found in polycystin-2-defective cholangiocytes, where polycystin-2 was suggested to play a role in SOCE activation and in inhibiting the STIM-dependent activation of AC6 . In view of the observation that polycystin-1 expression impairs translocation of STIM to the plasma membrane, this mechanism could also link polycystin-1 defects to increased cAMP signaling in ADPKD [41, 96].
Effects on B-Raf-extracellular signal-regulated kinase (ERK) signaling and cell proliferation (Fig. 2)
Effects on mammalian target of rapamycin (mTOR) signaling (Fig. 2)
Cyst-lining epithelial cells exhibit higher levels of mTOR signaling as compared to normal epithelial cells . mTOR is a serine/threonine protein kinase that provides catalytic activity for two distinct multiprotein complexes (mTORC1 and mTORC2). mTORC1 is a metabolic sensor and its activation promotes cell growth and cell proliferation. The effects of mTORC2 include modulation of cell survival, cytoskeletal organization, and cell polarity . Hyperactivity of mTORC1 and possibly also of mTORC2, contributes to cyst formation . Tuberin, the protein product of Tsc2, in a complex with hamartin, the product of Tsc1, is the primary negative regulator of mTORC1. Tuberin is a GTPase-activating protein (GAP), which regulates Rheb, a small G-protein belonging to the Ras superfamily. Hamartin and tuberin form a heterodimer, which converts Rheb-GTP to the inactive Rheb-GDP. Rheb is an activator of mTORC1 and conversion of Rheb to the GDP-bond form inactivates the mTORC1 pathway [120, 121, 122, 123]. The tuberin–hamartin complex is a nodal point for several polycystin-dependent pathways. The cytoplasmic tail of polycystin-1 interacts with tuberin. This may occur via direct interaction with tuberin  or indirectly via ERK-dependent phosphorylation and inactivation of the tuberin complex . A prominent activation of the ERK pathway together with cystogenesis was found upon inactivation of the Pkd1 gene in conditional knock-out mice . The regulation may, however, be more complex as tuberin has been reported to be phosphorylated by at least nine distinct protein kinases . Among these are multiple pathways that may be linked to proper functioning of polycystins and some of these are clearly linked to Ca2+ (Fig. 2). As explained above, a potential link with Ca2+ and cAMP may occur via B-Raf/ERK signaling. The lower Ca2+ levels in cystic cells would together with the increased cAMP concentration lead to activation of B-Raf/ERK and subsequent mTORC1 signaling [42, 114, 115]. Another mechanistic input of polycystins on mTORC1 is via ciliar activation of liver kinase B1 (LKB1), which, like the polycystins, is localized in the basal bodies of primary cilia . LKB1 activates AMP-activated protein kinase (AMPK), which then activates tuberin with subsequent negative regulation of mTORC1. This cilium-mediated effect on mTOR was, however, found to be independent of flow-induced Ca2+ transients or AKT . Next to LKB1, however, AMPK activity is also directly linked to the cytosolic Ca2+ concentration by calmodulin-dependent protein kinase kinase ß (CaMKKβ) . The link between the changed cytosolic Ca2+ concentration in cystic cells and mTORC1 via CaMKKβ-dependent regulation of AMPK is, however, not yet established. A relation between AMPK activity and cyst formation was, however, found by using metformin, a drug in wide clinical use as a pharmacological activator of AMPK . Stimulation of AMPK activity by metformin resulted in inhibition of the mTOR pathway and significant arrest of cystic growth in in vitro and ex vivo models of renal cystogenesis .
Additional pathways may converge on mTOR signaling in a Ca2+-dependent way. Wnt signaling, which was shown to be regulated by polycystin-1 , can activate a ß-catenin-dependent (canonical) and a ß-catenin-independent (non-canonical) pathway. In addition, a Wnt-Ca2+ pathway influences both canonical and non-canonical pathways . Inversin, a ciliar protein, functions as a molecular switch between the different Wnt signaling pathways . It can be speculated that ciliary events as flow-induced Ca2+ influx can switch off the canonical and activate the non-canonical pathway . Over-activation of canonical Wnt and subsequent over-production of activated ß-catenin would promote the polycystic phenotype . This is further supported by many observations showing a link between disturbed polycystin function and enhanced activity of Wnt signaling [130, 134, 135, 136]. In addition, the Wnt pathway is also able to act on mTOR via AMPK and GSK3  (Fig. 2). Tuberin was reported to be a physiological substrate of GSK3, which required priming phosphorylation by AMPK. Canonical Wnt then activates mTOR via inhibiting GSK3 phosphorylation of tuberin . Moreover, GSK3ß was shown to be activated by polycystin-1 . In ADPKD, disturbed polycystin-1 function and disturbed Ca2+ signaling may thus both contribute to a GSK3-dependent increase in mTOR activity .
Ca2+ signaling is implicated in the phenotypic feature of ADPKD cells showing elevated rates of both proliferation and apoptosis, but the downstream mechanisms are not fully resolved. It was found that polycystin-1 induces resistance to apoptosis and normal tubulogenesis through the PI3-K/AKT pathway  (Fig. 3). These data are consistent with observations that loss of polycystin-1 function results in changes in cytosolic Ca2+ concentration, down-regulation of PI3-K/AKT and activation of B-Raf/ERK in ADPKD cysts . As already outlined above, the disturbed intracellular Ca2+ signaling could be a primary event in ADPKD and may be responsible for the switch to a proliferative phenotype with an elevation in B-Raf protein levels and cAMP-stimulated, Ras-dependent activation of B-Raf and ERK [114, 115]. Also, a PKD2 transgenic mouse model resulted in renal-cys formation via B-Raf signaling, probably by acting as a dominant negative modulator for polycystin function and downstream Ca2+ signals . Pkd2 +/− vascular smooth-muscle cells also have an abnormal phenotype with a defective Ca2+ signaling with decreased levels of the cytosolic Ca2+ and an increased cellular cAMP concentration, which is probably underpinning increased proliferation and apoptosis . The low cytosolic Ca2+ concentration apparently provoked increased proliferation in these vascular smooth-muscle cells but the effect in this cell type was independent of cAMP/B-Raf signaling .
A divergent mechanism was proposed, in which disturbed polycystin-1 function affected cell proliferation by an increase in intracellular Ca2+ signaling in the form of activation of Ca2+ oscillations  (Fig. 2). Serum treatment of HEK293 cells with down-regulated polycystin-1 or of cystic cells expressing mutated polycystin-1 resulted in increased oscillatory activity of the cytosolic Ca2+ concentration which led to activation of cell proliferation. The proposed mechanism involved non-capacitative Ca2+ entry (NCCE), which was proposed to be negatively regulated by polycystin-1. The loss of polycystin-1 resulted in NCCE activation and increased Ca2+ oscillations. The downstream effects were related to activation of the calcineurin/nuclear factor of activated T cells (NFAT) pathway. The explanation could be that Ca2+ oscillations rather than the basal Ca2+ concentration are crucial for activation of the NFAT-dependent cell proliferation .
Another important factor, particularly for the increased apoptosis in ADPKD, could be the regulation of the ER Ca2+ content by polycystins  (Fig. 3). The ER Ca2+ content is determined by the activity of Ca2+ pumps and by the Ca2+-leak rate via different pathways. The resulting ER Ca2+ load is a primary determinant of the extent of ER-to-mitochondrial Ca2+ transfer and pro-apoptotic Ca2+ signaling . Polycystin-2 in the ER may act as a Ca2+-leak pathway and in this way control the degree of ER Ca2+ filling . Normal polycystin-2 functioning would then reduce Ca2+ release from the ER in response to apoptotic stimuli, and conversely, its loss in ADPKD would lead to an increased apoptosis . Although this mechanism may provide a simple molecular explanation for the increased apoptosis rate in ADPKD upon loss of polycystin-2 function, the situation may be more complex. As discussed above, polycystin-2 activity and its modulation of ER Ca2+ are probably tightly regulated by many other cellular factors and interacting proteins. Not only is polycystin-2 a Ca2+ channel but it also interacts with the two main intracellular Ca2+-release channels, IP3Rs and RyRs, and with various plasma-membrane TRP channels. Polycystin-1 controls the activity of polycystin-2 directly and also in an indirect way via PI3-K/AKT signaling. Decreased PI3-K/AKT signaling in ADPKD would thereby lead to a profound remodeling with increased IICR and SOCE (Fig. 3). This results from activation of Ca2+ release via polycystin-2, but also from a higher IP3R activity resulting from the relieve of the brake imposed by AKT-mediated phosphorylation . Increased IICR, particularly at the contact sites of the ER and mitochondria, constitutes a strong apoptotic signal [84, 170].
In conclusion, disturbed or remodeled cellular Ca2+ signaling is clearly a very early event in the development of the cystic phenotype of renal cells. This phenotype is characterized by a concomitant activation of both cell proliferation and apoptotic cell death. Despite the increased proliferation as an invariable component of cystogenesis, there is seldom progression towards renal carcinoma . Overexpression of polycystin-1 provoked apoptosis in different cancer cell lines, and it is tempting to speculate that polycystins, by controlling the balance between proliferation and cell death, may play a role in preventing malignant transformation . ADPKD epithelial cells are thereby characterized by a modest degree of cell proliferation together with a proportional increase in apoptosis [139, 140, 146, 153, 157, 172]. Both polycystins are closely involved in cellular Ca2+ signaling by direct or indirect interaction with many proteins of the cellular Ca2+ toolkit. It becomes increasingly evident that polycystin dysfunctions lead to a profound remodeling of cellular Ca2+ signaling and provoke changes in the spatio-temporal modes of Ca2+ signaling. This could lead to changes in the occurrence of different Ca2+-signaling microdomains located at the cilia or at the ER-mitochondria junctions, and it could lead to oscillatory Ca2+ signals that may evoke nuclear responses. It will be a challenge for future research to experimentally detect the subcellular Ca2+-signaling microdomains and to identify their downstream responses that result in the increased proliferation and increased apoptosis responses, which are characteristic for the cystic phenotype.
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
- 17.Qian F, Boletta A, Bhunia AK, Xu H, Liu L, Ahrabi AK, Watnick TJ, Zhou F, Germino GG (2002) Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations. Proc Natl Acad Sci USA 99:16981–16986PubMedCrossRefGoogle Scholar
- 20.Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S (1996) PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272:1339–1342PubMedCrossRefGoogle Scholar
- 29.Kottgen M, Benzing T, Simmen T, Tauber R, Buchholz B, Feliciangeli S, Huber TB, Schermer B, Kramer-Zucker A, Hopker K, Simmen KC, Tschucke CC, Sandford R, Kim E, Thomas G, Walz G (2005) Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation. EMBO J 24:705–716PubMedCrossRefGoogle Scholar
- 31.Wilson PD (1997) Epithelial cell polarity and disease. Am J Physiol Renal Physiol 272:F434–F442Google Scholar
- 35.Zhang P, Luo Y, Chasan B, Gonzalez-Perrett S, Montalbetti N, Timpanaro GA, Cantero Mdel R, Ramos AJ, Goldmann WH, Zhou J, Cantiello HF (2009) The multimeric structure of polycystin-2 (TRPP2): structural-functional correlates of homo- and hetero-multimers with TRPC1. Hum Mol Genet 18:1238–1251PubMedCrossRefGoogle Scholar
- 36.Kottgen M, Buchholz B, Garcia-Gonzalez MA, Kotsis F, Fu X, Doerken M, Boehlke C, Steffl D, Tauber R, Wegierski T, Nitschke R, Suzuki M, Kramer-Zucker A, Germino GG, Watnick T, Prenen J, Nilius B, Kuehn EW, Walz G (2008) TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 182:437–447PubMedCrossRefGoogle Scholar
- 38.Sammels E, Devogelaere B, Mekahli D, Bultynck G, Missiaen L, Parys JB, Cai Y, Somlo S, De Smedt H (2010) Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 285:18794–18805PubMedCrossRefGoogle Scholar
- 52.Giamarchi A, Feng S, Rodat-Despoix L, Xu Y, Bubenshchikova E, Newby LJ, Hao J, Gaudioso C, Crest M, Lupas AN, Honore E, Williamson MP, Obara T, Ong AC, Delmas P (2010) A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes. EMBO J 29:1176–1191PubMedCrossRefGoogle Scholar
- 57.Gonzalez-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF (2001) Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci USA 98:1182–1187PubMedCrossRefGoogle Scholar
- 60.Vassilev PM, Guo L, Chen XZ, Segal Y, Peng JB, Basora N, Babakhanlou H, Cruger G, Kanazirska M, Ye C, Brown EM, Hediger MA, Zhou J (2001) Polycystin-2 is a novel cation channel implicated in defective intracellular Ca2+ homeostasis in polycystic kidney disease. Biochem Biophys Res Commun 282:341–350PubMedCrossRefGoogle Scholar
- 80.Xu C, Rossetti S, Jiang L, Harris PC, Brown-Glaberman U, Wandinger-Ness A, Bacallao R, Alper SL (2007) Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. Am J Physiol Renal Physiol 292:F930–F945PubMedCrossRefGoogle Scholar
- 95.Manzati E, Aguiari G, Banzi M, Manzati M, Selvatici R, Falzarano S, Maestri I, Pinton P, Rizzuto R, del Senno L (2005) The cytoplasmic C-terminus of polycystin-1 increases cell proliferation in kidney epithelial cells through serum-activated and Ca2+-dependent pathway(s). Exp Cell Res 304:391–406PubMedCrossRefGoogle Scholar
- 100.Mekahli D, Sammels E, Luyten T, Welkenhuyzen K, van den Heuvel LP, Levtchenko EN, Gijsbers R, Bultynck G, Parys JB, De Smedt H, Missiaen L (2012) Polycystin-1 and polycystin-2 are both required to amplify inositol-trisphosphate-induced Ca2+ release. Cell Calcium 51:452–458PubMedCrossRefGoogle Scholar
- 103.Hanaoka K, Devuyst O, Schwiebert EM, Wilson PD, Guggino WB (1996) A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol Cell Physiol 270:C389–C399Google Scholar
- 106.Choi YH, Suzuki A, Hajarnis S, Ma Z, Chapin HC, Caplan MJ, Pontoglio M, Somlo S, Igarashi P (2011) Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases. Proc Natl Acad Sci USA 108:10679–10684PubMedCrossRefGoogle Scholar
- 110.Spirli C, Locatelli L, Fiorotto R, Morell CM, Fabris L, Pozzan T, Strazzabosco M (2012) Altered store operated calcium entry increases cyclic 3′,5′-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes. Hepatology 55:856–868PubMedCrossRefGoogle Scholar
- 111.Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, Grantham JJ (2000) cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57:1460–1471PubMedCrossRefGoogle Scholar
- 119.Shillingford JM, Murcia NS, Larson CH, Low SH, Hedgepeth R, Brown N, Flask CA, Novick AC, Goldfarb DA, Kramer-Zucker A, Walz G, Piontek KB, Germino GG, Weimbs T (2006) The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 103:5466–5471PubMedCrossRefGoogle Scholar
- 124.Distefano G, Boca M, Rowe I, Wodarczyk C, Ma L, Piontek KB, Germino GG, Pandolfi PP, Boletta A (2009) Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6 K and 4EBP1. Mol Cell Biol 29:2359–2371PubMedCrossRefGoogle Scholar
- 125.Shibazaki S, Yu Z, Nishio S, Tian X, Thomson RB, Mitobe M, Louvi A, Velazquez H, Ishibe S, Cantley LG, Igarashi P, Somlo S (2008) Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1. Hum Mol Genet 17:1505–1516PubMedCrossRefGoogle Scholar
- 127.Boehlke C, Kotsis F, Patel V, Braeg S, Voelker H, Bredt S, Beyer T, Janusch H, Hamann C, Godel M, Muller K, Herbst M, Hornung M, Doerken M, Kottgen M, Nitschke R, Igarashi P, Walz G, Kuehn EW (2010) Primary cilia regulate mTORC1 activity and cell size through Lkb1. Nat Cell Biol 12:1115–1122PubMedCrossRefGoogle Scholar
- 132.Simons M, Gloy J, Ganner A, Bullerkotte A, Bashkurov M, Kronig C, Schermer B, Benzing T, Cabello OA, Jenny A, Mlodzik M, Polok B, Driever W, Obara T, Walz G (2005) Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat Genet 37:537–543PubMedCrossRefGoogle Scholar
- 135.Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peters DJ (2009) Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet 18:2532–2542PubMedCrossRefGoogle Scholar
- 136.Romaker D, Puetz M, Teschner S, Donauer J, Geyer M, Gerke P, Rumberger B, Dworniczak B, Pennekamp P, Buchholz B, Neumann HP, Kumar R, Gloy J, Eckardt KU, Walz G (2009) Increased expression of secreted frizzled-related protein 4 in polycystic kidneys. J Am Soc Nephrol 20:48–56PubMedCrossRefGoogle Scholar
- 137.Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO, Guan KL (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126:955–968PubMedCrossRefGoogle Scholar
- 138.Boca M, D’Amato L, Distefano G, Polishchuk RS, Germino GG, Boletta A (2007) Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell–cell mechanical adhesion. Mol Biol Cell 18:4050–4061PubMedCrossRefGoogle Scholar
- 169.Szado T, Vanderheyden V, Parys JB, De Smedt H, Rietdorf K, Kotelevets L, Chastre E, Khan F, Landegren U, Soderberg O, Bootman MD, Roderick HL (2008) Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc Natl Acad Sci USA 105:2427–2432PubMedCrossRefGoogle Scholar